Selected research
Market Structure
Global Prenatal Screening Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Prenatal Screening market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Prenatal Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Prenatal Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Prenatal Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Prenatal Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Prenatal Screening include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB and Veritas Genetics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Prenatal Screening market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Prenatal Screening and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Prenatal Screening revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Prenatal Screening market size, projected growth trends, production technologies, key applications, and end-use industries.
Prenatal Screening Segment by Company
Thermo Fisher Scientific
Revvity
Quest Diagnostics
MedGenome
Mayo Clinic Laboratories
GeneDx
PreventionGenetics
SYNLAB
Veritas Genetics
GGA
Cordlife
Rainbow Genomics
BGI Genomics
Berry Genomics
Annaroad
Jiajian Medical Testing
Genesky
Weihansi Biomedical Technology
Prenatal Screening Segment by Type
Serum Biomarker Screening
Ultrasonographic Imaging Screening
Others
Prenatal Screening Segment by Application
Public Hospitals
Private Hospitals
Prenatal Screening Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prenatal Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prenatal Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prenatal Screening.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Prenatal Screening in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prenatal Screening industry.
Chapter 3: Detailed analysis of Prenatal Screening companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prenatal Screeningrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Serum Biomarker Screening
- Ultrasonographic Imaging Screening
- Others
Applications
- Public Hospitals
- Private Hospitals
Companies covered
- Thermo Fisher Scientific
- Revvity
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- GeneDx
- PreventionGenetics
- SYNLAB
- Veritas Genetics
- GGA
- Cordlife
- Rainbow Genomics
- BGI Genomics
- Berry Genomics
- Annaroad
- Jiajian Medical Testing
- Genesky
- Weihansi Biomedical Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Prenatal Screening Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Serum Biomarker Screening
- 1.2.3 Ultrasonographic Imaging Screening
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Prenatal Screening Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Public Hospitals
- 1.3.3 Private Hospitals
- 1.4 Global Market Growth Prospects
- 1.5 Global Prenatal Screening Growth Trends by Region
- 1.5.1 Global Prenatal Screening Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Prenatal Screening Market Size by Region (2021-2026)
- 1.5.3 Prenatal Screening Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Prenatal Screening Market Dynamics
- 2.1 Prenatal Screening Industry Trends
- 2.2 Prenatal Screening Industry Drivers
- 2.3 Prenatal Screening Industry Opportunities and Challenges
- 2.4 Prenatal Screening Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Prenatal Screening Revenue by Company (2021-2026)
- 3.2 Global Prenatal Screening Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Prenatal Screening Key Company Head office and Area Served
- 3.4 Global Prenatal Screening Company, Product Type & Application
- 3.5 Global Prenatal Screening Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Prenatal Screening Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Prenatal Screening Players Market Share by Revenue in 2025
- 3.6.3 2025 Prenatal Screening Tier 1, Tier 2, and Tier 3
4 Prenatal Screening Market by Type
- 4.1 Global Prenatal Screening Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Prenatal Screening Market Size by Type (2021-2032)
- 4.3 Global Prenatal Screening Market Size Share by Type (2021-2032)
5 Prenatal Screening Market by Application
- 5.1 Global Prenatal Screening Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Prenatal Screening Market Size by Application (2021-2032)
- 5.3 Global Prenatal Screening Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Thermo Fisher Scientific Prenatal Screening Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Revvity
- 6.2.1 Revvity Company Information
- 6.2.2 Revvity Business Overview
- 6.2.3 Revvity Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Revvity Prenatal Screening Product Portfolio
- 6.2.5 Revvity Recent Developments
- 6.3 Quest Diagnostics
- 6.3.1 Quest Diagnostics Company Information
- 6.3.2 Quest Diagnostics Business Overview
- 6.3.3 Quest Diagnostics Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Quest Diagnostics Prenatal Screening Product Portfolio
- 6.3.5 Quest Diagnostics Recent Developments
- 6.4 MedGenome
- 6.4.1 MedGenome Company Information
- 6.4.2 MedGenome Business Overview
- 6.4.3 MedGenome Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 MedGenome Prenatal Screening Product Portfolio
- 6.4.5 MedGenome Recent Developments
- 6.5 Mayo Clinic Laboratories
- 6.5.1 Mayo Clinic Laboratories Company Information
- 6.5.2 Mayo Clinic Laboratories Business Overview
- 6.5.3 Mayo Clinic Laboratories Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Mayo Clinic Laboratories Prenatal Screening Product Portfolio
- 6.5.5 Mayo Clinic Laboratories Recent Developments
- 6.6 GeneDx
- 6.6.1 GeneDx Company Information
- 6.6.2 GeneDx Business Overview
- 6.6.3 GeneDx Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 GeneDx Prenatal Screening Product Portfolio
- 6.6.5 GeneDx Recent Developments
- 6.7 PreventionGenetics
- 6.7.1 PreventionGenetics Company Information
- 6.7.2 PreventionGenetics Business Overview
- 6.7.3 PreventionGenetics Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 PreventionGenetics Prenatal Screening Product Portfolio
- 6.7.5 PreventionGenetics Recent Developments
- 6.8 SYNLAB
- 6.8.1 SYNLAB Company Information
- 6.8.2 SYNLAB Business Overview
- 6.8.3 SYNLAB Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 SYNLAB Prenatal Screening Product Portfolio
- 6.8.5 SYNLAB Recent Developments
- 6.9 Veritas Genetics
- 6.9.1 Veritas Genetics Company Information
- 6.9.2 Veritas Genetics Business Overview
- 6.9.3 Veritas Genetics Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Veritas Genetics Prenatal Screening Product Portfolio
- 6.9.5 Veritas Genetics Recent Developments
- 6.10 GGA
- 6.10.1 GGA Company Information
- 6.10.2 GGA Business Overview
- 6.10.3 GGA Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 GGA Prenatal Screening Product Portfolio
- 6.10.5 GGA Recent Developments
- 6.11 Cordlife
- 6.11.1 Cordlife Company Information
- 6.11.2 Cordlife Business Overview
- 6.11.3 Cordlife Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Cordlife Prenatal Screening Product Portfolio
- 6.11.5 Cordlife Recent Developments
- 6.12 Rainbow Genomics
- 6.12.1 Rainbow Genomics Company Information
- 6.12.2 Rainbow Genomics Business Overview
- 6.12.3 Rainbow Genomics Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Rainbow Genomics Prenatal Screening Product Portfolio
- 6.12.5 Rainbow Genomics Recent Developments
- 6.13 BGI Genomics
- 6.13.1 BGI Genomics Company Information
- 6.13.2 BGI Genomics Business Overview
- 6.13.3 BGI Genomics Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 BGI Genomics Prenatal Screening Product Portfolio
- 6.13.5 BGI Genomics Recent Developments
- 6.14 Berry Genomics
- 6.14.1 Berry Genomics Company Information
- 6.14.2 Berry Genomics Business Overview
- 6.14.3 Berry Genomics Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Berry Genomics Prenatal Screening Product Portfolio
- 6.14.5 Berry Genomics Recent Developments
- 6.15 Annaroad
- 6.15.1 Annaroad Company Information
- 6.15.2 Annaroad Business Overview
- 6.15.3 Annaroad Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Annaroad Prenatal Screening Product Portfolio
- 6.15.5 Annaroad Recent Developments
- 6.16 Jiajian Medical Testing
- 6.16.1 Jiajian Medical Testing Company Information
- 6.16.2 Jiajian Medical Testing Business Overview
- 6.16.3 Jiajian Medical Testing Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Jiajian Medical Testing Prenatal Screening Product Portfolio
- 6.16.5 Jiajian Medical Testing Recent Developments
- 6.17 Genesky
- 6.17.1 Genesky Company Information
- 6.17.2 Genesky Business Overview
- 6.17.3 Genesky Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Genesky Prenatal Screening Product Portfolio
- 6.17.5 Genesky Recent Developments
- 6.18 Weihansi Biomedical Technology
- 6.18.1 Weihansi Biomedical Technology Company Information
- 6.18.2 Weihansi Biomedical Technology Business Overview
- 6.18.3 Weihansi Biomedical Technology Prenatal Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Weihansi Biomedical Technology Prenatal Screening Product Portfolio
- 6.18.5 Weihansi Biomedical Technology Recent Developments
7 North America
- 7.1 North America Prenatal Screening Market Size (2021-2032)
- 7.2 North America Prenatal Screening Market Size by Type
- 7.2.1 North America Prenatal Screening Market Size by Type (2021-2026)
- 7.2.2 North America Prenatal Screening Market Size by Type (2027-2032)
- 7.2.3 North America Prenatal Screening Market Share by Type (2021-2032)
- 7.3 North America Prenatal Screening Market Size by Application
- 7.3.1 North America Prenatal Screening Market Size by Application (2021-2026)
- 7.3.2 North America Prenatal Screening Market Size by Application (2027-2032)
- 7.3.3 North America Prenatal Screening Market Share by Application (2021-2032)
- 7.4 North America Prenatal Screening Market Size by Country
- 7.4.1 North America Prenatal Screening Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Prenatal Screening Market Size by Country (2021-2026)
- 7.4.3 North America Prenatal Screening Market Size by Country (2027-2032)
- 7.4.4 North America Prenatal Screening Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Prenatal Screening Market Size (2021-2032)
- 8.2 Europe Prenatal Screening Market Size by Type
- 8.2.1 Europe Prenatal Screening Market Size by Type (2021-2026)
- 8.2.2 Europe Prenatal Screening Market Size by Type (2027-2032)
- 8.2.3 Europe Prenatal Screening Market Share by Type (2021-2032)
- 8.3 Europe Prenatal Screening Market Size by Application
- 8.3.1 Europe Prenatal Screening Market Size by Application (2021-2026)
- 8.3.2 Europe Prenatal Screening Market Size by Application (2027-2032)
- 8.3.3 Europe Prenatal Screening Market Share by Application (2021-2032)
- 8.4 Europe Prenatal Screening Market Size by Country
- 8.4.1 Europe Prenatal Screening Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Prenatal Screening Market Size by Country (2021-2026)
- 8.4.3 Europe Prenatal Screening Market Size by Country (2027-2032)
- 8.4.4 Europe Prenatal Screening Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Prenatal Screening Market Size (2021-2032)
- 9.2 China Prenatal Screening Market Size by Type
- 9.2.1 China Prenatal Screening Market Size by Type (2021-2026)
- 9.2.2 China Prenatal Screening Market Size by Type (2027-2032)
- 9.2.3 China Prenatal Screening Market Share by Type (2021-2032)
- 9.3 China Prenatal Screening Market Size by Application
- 9.3.1 China Prenatal Screening Market Size by Application (2021-2026)
- 9.3.2 China Prenatal Screening Market Size by Application (2027-2032)
- 9.3.3 China Prenatal Screening Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Prenatal Screening Market Size (2021-2032)
- 10.2 Asia Prenatal Screening Market Size by Type
- 10.2.1 Asia Prenatal Screening Market Size by Type (2021-2026)
- 10.2.2 Asia Prenatal Screening Market Size by Type (2027-2032)
- 10.2.3 Asia Prenatal Screening Market Share by Type (2021-2032)
- 10.3 Asia Prenatal Screening Market Size by Application
- 10.3.1 Asia Prenatal Screening Market Size by Application (2021-2026)
- 10.3.2 Asia Prenatal Screening Market Size by Application (2027-2032)
- 10.3.3 Asia Prenatal Screening Market Share by Application (2021-2032)
- 10.4 Asia Prenatal Screening Market Size by Country
- 10.4.1 Asia Prenatal Screening Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Prenatal Screening Market Size by Country (2021-2026)
- 10.4.3 Asia Prenatal Screening Market Size by Country (2027-2032)
- 10.4.4 Asia Prenatal Screening Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Prenatal Screening Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Prenatal Screening Market Size by Type
- 11.2.1 South America, Middle East & Africa Prenatal Screening Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Prenatal Screening Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Prenatal Screening Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Prenatal Screening Market Size by Application
- 11.3.1 South America, Middle East & Africa Prenatal Screening Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Prenatal Screening Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Prenatal Screening Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Prenatal Screening Market Size by Country
- 11.4.1 South America, Middle East & Africa Prenatal Screening Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Prenatal Screening Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Prenatal Screening Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Prenatal Screening Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst